Senores Pharmaceuticals Limited — Outcome of Board Meeting

Senores Pharmaceuticals Limited has informed the stock exchange that its board of directors held a meeting on October 29, 2026. The company has submitted the formal outcome of this meeting to the exchange, though the specific agenda items discussed have not been disclosed in the public announcement.

This update is a routine corporate governance requirement and does not, by itself, signal any major corporate action. For investors, the key will be to wait for the official disclosure to understand if the board approved any significant financial decisions, strategic initiatives, or policy changes.

Investors should monitor the company's future press releases or regulatory filings for details on the board's decisions. Until the specific outcome is disclosed, the stock's movement will likely remain driven by broader market sentiment rather than this specific corporate update.